Use of thyroid hormones in euthyroid patients with unexplained fatigue: analyses of aggregate data from European national surveys of professional endocrine society members

A small, yet not negligible percentage of European thyroid-focused physicians consider using TH for euthyroid patients with unexplained fatigue, with significant variations based on geographic, demographic, and practice-related factors. Using levothyroxine and/or liothyronine in such cases lacks evidence and may partially contribute to the concerning overuse of TH therapy.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2025-11-05
DOI
https://doi.org/10.3389/fendo.2025.1713814
Primary Topic
Thyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Use of thyroid hormones in euthyroid patients with unexplained fatigue: analyses of aggregate data from European national surveys of professional endocrine society members

Roberto Attanasio, Ersin Akarsu, D Niculescu, Maria Alevizaki et al.
Frontiers in Endocrinology
Thyroid Disorders and Treatments
article

Use of thyroid hormones in euthyroid patients with unexplained fatigue: analyses of aggregate data from European national surveys of professional endocrine society members

Roberto Attanasio, Ersin Akarsu, D Niculescu, Maria Alevizaki, Chagit Adler Cohen, Cătălina Poiană, Juan C. Galofré, Harald Dobnig, Roberto Negro, Laurence Leenhardt, Maria‐Cristina Burlacu, Petros Perros, М.D. Тronko, Marek Ruchała, Eszter Berta, Т. Б. Моргунова, Alla Shepelkevich, Anna-Maria Borissova, Stephen Ludgate, Enrico Papini, Andromachi Vryonidou, Miguel Melo, Martin Kužma, W. Edward Visser, Michal Kršek, László Hegedüs, Saara Metso, David Unuane, Anne McGowan, Francisca Marques Puga, Jacob Stampe Frølich, Tereza Planck, Mihail Boyanov, Eyal Robenshtok, Younes R. Younes, Elena Yurenya, Camille Buffet, Michael Krebs, Peter Kopp, Jan Jiskra, Irfan Vardarli, Kamilla Ryom Riis, Biljana Nedeljković-Beleslin, Tomasz Bednarczuk, Eric Fliers, Ivica Lazúrová, Miklós Bodor, Miloš Žarković, Juan J. Díez, Benjamin C. T. Field, Tommi Hakala, Endre Vezekenyi Nagy, Göksün Ayvaz, Carla Moran, Božidar Perić, Patrick Olivier Rosselet, J. Ćirić, Dagmar Führer‐Sakel, Valentin Fadeyev, Vitaliy Luchytskiy, Aleksandra Sugier
article en

Abstract

A small, yet not negligible percentage of European thyroid-focused physicians consider using TH for euthyroid patients with unexplained fatigue, with significant variations based on geographic, demographic, and practice-related factors. Using levothyroxine and/or liothyronine in such cases lacks evidence and may partially contribute to the concerning overuse of TH therapy.

Frontiers in EndocrinologyVol. 16
University College Dublin (IE), Poznan University of Medical Sciences (PL), Cliniques Universitaires Saint-Luc (BE), University of Debrecen (HU), Vrije Universiteit Brussel (BE), Carol Davila University of Medicine and Pharmacy (RO), Tel Aviv University (IL), Sechenov University (RU), National and Kapodistrian University of Athens (GR), University of Pavol Jozef Šafárik (SK), Trinity College Dublin (IE), Charles University (CZ), Heidelberg University (DE), Medical University of Warsaw (PL), Alexandrovska Hospital (BG), Rabin Medical Center (IL), Odense University Hospital (DK), East Surrey Hospital (GB), Beaumont Hospital (IE), Erasmus MC (NL), University Hospital Heidelberg (DE), Tallaght University Hospital (IE), University of Surrey (GB), Medical University of Sofia (BG), Hospital de São João (PT), Sorbonne Université (FR), University of Belgrade (RS), Noguchi Thyroid Clinic and Hospital Foundation (JP), Assistance Publique – Hôpitaux de Paris (FR), Hellenic Red Cross (GR), Memorial Ankara Hospital (TR), Red Cross Hospital (GR), Hospital Universitario Puerta de Hierro Majadahonda (ES), Navarre Institute of Health Research (ES), Alexandra Hospital (GR), St. Vincent's University Hospital (IE), Knappschaftskrankenhaus Recklinghausen (DE), Essen University Hospital (DE), Pitié-Salpêtrière Hospital (FR), Sisters of Charity Hospital (HR), Tampere University Hospital (FI), V.P. Komisarenko Institute of Endocrinology and Metabolism (UA), Tampere University (FI), Clinica Universidad de Navarra (ES), Skåne University Hospital (SE), Ospedale Regina Apostolorum (IT), Associazione Medici Diabetologi (IT), Instituto de Investigación Sanitaria de Santiago (ES), Amsterdam University Medical Centers (NL), Ospedale Vito Fazzi (IT), University Medical Centre Mannheim (DE), Surrey and Sussex Healthcare NHS Trust (GB), Groupe de recherche clinique – Tumeurs Thyroïdiennes, Belarusian State Medical University (BY), Sofia University "St. Kliment Ohridski" (BG), Gaziantep University (TR), Universidad Autónoma de Madrid (ES), Comenius University Bratislava (SK), Medical University of Vienna (AT), University of Coimbra (PT), Newcastle University (GB), University of Amsterdam (NL), Erasmus University Rotterdam (NL), UCLouvain (BE), University of Lausanne (CH)
Openalex Percentile: Top 56%
Thyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.